Abstract

The high iodine content of amiodarone precludes its use at any dose without at least a magnitude increase in exposure to iodine. A 200 mg tablet contains 75 mg of iodine, or which 7.5 mg is bioavailable, rapidly dwarfing the normal total body content of 14 mg. Hyperthyroidism is observed in about 3.3% of individuals in populations exposed to an increase in environmental iodine through increased salt fortification, water purification or seaweed ingestion. Study of linked prescription/clinical databases confirms that patients taking amiodarone and thus exposed to excess iodine, also experience hyperthyroidism at a rate of 3-4%. This suggests they are reacting to iodine rather than the peripheral pharmacological effect of amiodarone on thyroxine conversion to triiodothyronine. We studied the incidence of hyperthyroidism in patients enrolling in the Calgary Amiodarone Clinic and compared it to personal experience in other Canadian cities.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.